Biosynthetic oligoclonal antivenom (BOA) for snakebite and next-generation treatments for snakebite victims †

Biosynthetic oligoclonal antivenom (BOA) for snakebite and next-generation treatments for snakebite victims †

10.3390/toxins10120534

Saved in:

Bibliographic Details
Main Authors:	Kini, R.M, Sidhu, S.S, Laustsen, A.H
Other Authors:	BIOLOGICAL SCIENCES
Format:	Article
Published:	2020
Subjects:	biosynthetic oligoclonal antivenom enzyme inhibitor immunoglobulin G neutralizing antibody recombinant antibody single chain fragment variable antibody small molecule enzyme inhibitor snake venom snake venom antiserum unclassified drug monoclonal antibody recombinant protein venom antiserum allergic reaction anaphylaxis antibody production Article cross reaction drug efficacy drug potentiation drug safety fever geographical variation (species) human immunization morbidity mortality pathophysiology phage display pharmacodynamics protein expression serum sickness snakebite snakebite envenoming tissue injury animal Animals Antibodies, Monoclonal Antivenins Humans Recombinant Proteins Snake Bites
Online Access:	https://scholarbank.nus.edu.sg/handle/10635/177804
Tags:	Add Tag No Tags, Be the first to tag this record!
Institution:	National University of Singapore

Description
Summary:	10.3390/toxins10120534